Applications of 3-Bromo-2-Chlorothiophene in Industrial Manufacturing

As the direct manufacturer of 3-Bromo-2-Chlorothiophene, we engage closely with downstream partners in advanced chemical synthesis, ensuring reliable supply and technical support for core intermediates. The following applications demonstrate where this compound delivers irreplaceable value, based on real-world practices in pharmaceutical, agrochemical, and electronic material segments.

1. Active Pharmaceutical Ingredient (API) Intermediate Synthesis

Large-volume pharmaceutical manufacturers routinely procure our product to construct substituted thiophene rings in proprietary API molecules, addressing rising demand for heterocyclic drugs. Process chemists exploit its dual halogen substitution for efficient C–C and C–N bond transformations, especially in anti-infective and central nervous system research pipelines. The aromatic reactivity profile enables targeted regioselective synthesis, supporting strict raw material traceability under regulatory monitoring.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP & EP (pharmacopoeial reference for intermediates)
• EU REACH registration for raw material traceability
• US FDA DMF (where applicable for intermediate notification)

Typical usage ratio

• Mixing ratio of 5–20% by molar equivalence in the initial heterocycle construction; adjusted depending on target molecule structure and reaction sequence.

Downstream process integration

• Introduced during primary condensation or cross-coupling steps, often via Grignard, Suzuki, or Buchwald-Hartwig pathways; strictly monitored for residual impurities in subsequent purification.

Final product types

• Anti-infective agents (e.g., cephalosporins with modified thiophene rings)
• Neuroactive drugs with sulfur heterocycles
• Experimental oncology compounds in clinical development

2. Agrochemical Intermediate for Herbicide and Fungicide Synthesis

Process engineers in agricultural chemistry utilize it as a core scaffold to synthesize heterocyclic herbicide and fungicide actives, favoring its unique substitution pattern for downstream functionalization. Key industry adopters leverage its stable structure in large-scale batch or flow processing, meeting lifecycle management requirements for regulated actives in multiple geographic regions.

Industry compliance standards

• FAO/WHO Specifications for Agricultural Pesticides
• China GB 2763 Maximum Residue Limits (MRLs) on crops
• EU Plant Protection Product Regulation (1107/2009/EC)
• ISO 9001 Quality Management for agrochemical manufacturing

Typical usage ratio

• Standard feedstock concentration at 10–30% relative to end-target molecule, fine-tuned based on chain length and substitution requirements in the synthesis sequence.

Downstream process integration

• Introduced during the aromatic substitution or halogen exchange stage; employed in closed system reactors for chlorothiophene-to-alkylation or nitration process steps; monitored for halide release and compliance with environmental containment protocols.

Final product types

• Chlorothiophene-based pre-emergent herbicide actives
• Systemic fungicide compounds with thiophene-derived cores
• Pesticide formulation intermediates subject to downstream blending

3. Organic Electronic Material Synthesis

Leading electronic material producers incorporate this chemical as a specialty monomer or coupling unit to produce functionalized thiophene oligomers and polymers, key to new-generation OLED, OFET, and organic solar cell research. Its defined bromo- and chloro- positions allow for reactivity control during polymerization, resulting in high-purity semiconducting films with reproducible batch characteristics that support high-performance device manufacturing.

Industry compliance standards

• RoHS 3 (EU Directive 2015/863) restriction of hazardous substances
• IEC 61249-2-21 halogen-free specifications (for electronic substrates)
• JPCA Guidelines for Printed Circuit Materials
• ISO 9001/14001 for electronic material supply chain

Typical usage ratio

• Monomer input typically ranges from 2–10 mol% in donor–acceptor copolymer synthesis; proportion varies based on molecular weight control objectives.

Downstream process integration

• Used in direct arylation, Stille, or Suzuki-Miyaura polymerization steps; enters as a monomer during controlled feed for thin-film fabrication or ink formulation.

Final product types

• High-mobility organic thin-film transistor (TFT) arrays
• OLED pixel emission layers
• Organic photovoltaic (OPV) active layer materials

4. Intermediate for Veterinary Drug Synthesis

Veterinary pharmaceutical plants engage this specialty intermediate to introduce thiophene moieties into new-generation anti-parasitic and anti-infective compounds. Application chemists pursue both selectivity and high-purity chain extension, supporting downstream syntheses with robust impurity control appropriate for animal health regulatory oversight. Usage in veterinary segment differs from human API synthesis due to additional residue, environmental, and animal safety monitoring mandates.

Industry compliance standards

• VICH GL24 (Stability Testing of New Veterinary Drug Substances and Medicinal Products)
• US FDA CVM Guidance for Industry #205 (Veterinary Drug Residue Control)
• EU Regulation (EU) 2019/6 on veterinary medicinal products
• GMP for Veterinary API Production

Typical usage ratio

• Dosed at 5–15% molar ratio equivalent in the intermediate condensation step; refinement depends on the total target batch size and scale-up efficiency.

Downstream process integration

• Fed in early-stage synthetic route, usually in mixed solvent conditions at controlled temperature; subjected to environmental monitoring during halide separation.

Final product types

• Veterinary dewormers containing thiophene derivatives
• Livestock anti-infective injectables
• Companion animal oral medications with sulfur-containing heterocycles